New estimates indicate that multiple sclerosis (MS) affects nearly 950,000 people in the United States—significantly more than previous estimates of 400,000. While still incurable, disease-modifying therapies can help keep the debilitating manifestations of MS at bay. Equally important for better outcomes are early diagnosis, general wellness efforts, and improved adherence to therapies. Primary care clinicians are in a unique position to partner with patients and specialists toward these goals, as will be discussed by two MS experts and demonstrated through patient simulations.
Audio- and video-enhanced slide lecture
To encourage primary care clinicians to be more vigilant for signs and symptoms of MS, refer patients to specialists when appropriate, and work as part of an interdisciplinary team to ensure the best possible outcomes for patients with MS.
After completing this activity, participants should be better able to:
- Recognize the early clinical symptoms of MS in order to facilitate prompt referral to specialist care for early diagnosis
- Counsel patients on the risks and benefits of current treatments for MS
- Implement strategies to promote long-term adherence to treatment and improve quality of life in patients with MS
Nurse practitioners and physician assistants
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 0.50 hours of pharmacology credit
CNE course advisor: Barbara S. Bishop, MS, ANP-C, MSCN, CNRN
This program has been reviewed and is approved for a maximum of 1.0 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of January 31, 2018. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity is supported by an educational grant from AbbVie Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, the AAPA, or AbbVie Inc.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are expected to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Coyle: consultant: AbbVie, Accordant, Acorda, Bayer, Biogen, Celgene, Genentech/Roche, Novartis, Sanofi Genzyme, Serono, Teva; grant/research support: Actelion, Alkermes, Genentech/Roche, MedDay, NINDS, Novartis.
Ms Boyd: consultant: Genzyme, Teva; speakers bureau: Biogen, EMD Serono, Teva.
The Planning Committee for this activity included Ruth Cohen and Warren Beckman of Continuing Education Alliance; Barbara Bishop, MS, ANP-C, MSCN, CNRN of Virginia Beach, VA; and Mark Christiansen, PhD, PA-C, of the University of the Pacific. The members of the Planning Committee have no relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Watch and listen to the presentation and study the program slides
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: January 31, 2018
Expiration date: January 31, 2019
© 2018 Practicing Clinicians Exchange. All Rights Reserved. APCE93517